Combination agent
CA 2436739 A1 · Owner: Ohkawa, Shigenori · Inventors: Miwatashi, Seiji; Naruo, Kenichi; Ohkawa, Shigenori
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Drugs comprising a combination of one or more p38MAP kinase inhibitors and/or TNF-a production inhibitors with one or more agents selected from the group consisting of: (1) nonsteroidal anti-inflammatory agents; (2) diseasemodification antirheumatics; (3) anti-cytokine drugs; (4) immunomodulators; (5) steroidal drugs; and (6) c-JUN N-terminal kinase inhibitors. These concomitant drugs are useful as preventives and remedies for diseases such as rheumatism and arthritis and other diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 25, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 25, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 25, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.